immunology

Pharma

Novartis expands Rhapsido's growing reach in chronic hives

After a first approval in chronic hives, Novartis’ Rhapsido is expanding its reach with a new FDA nod that comes with a notable ‘first’ for the field.

Fraiser Kansteiner Oct 7, 2026 2:27pm

Two hands with vitiligo holding each other

Litfulo and tilrekimig data bolster Pfizer's immunology plans

Oct 2, 2026 11:15am

AbbVie taps '26 cohort of immunology scholarship recipients

Aug 26, 2026 5:16pm

Pharma money pharma money pharma profits Big Pharma sales drug sales

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am

Biogen lays out $5.6B to acquire Apellis

Mar 31, 2026 10:32am

Galderma doubles Nemluvio peak sales outlook to $4B-plus

Mar 5, 2026 11:20am